Q2 2010

Source filing unavailable

Q2 2010 · —

Revenue

$1.21B

+10.9% vs Q2 2009

Net Income

$293.40M

+105.5% vs Q2 2009

EPS Diluted

$1.12

+128.6% vs Q2 2009

Gross Profit$1,105,700,000+10.3%

Operating Income$395,880,000+77.6%

Operating Cash Flowderived

Same quarter

Metric	Q2 2010	Q2 2009	Q2 2008
Revenue	$1.21B	$1.09B	$993.44M
Net Income	$293.40M	$142.80M	$206.63M
EPS Diluted	$1.12	$0.49	$0.70

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR